The University of Washington has published a study that suggests clinicians should offer non-pharmaceutical care for pain, fatigue, depression or anxiety at the time of diagnosis in patients with multiple sclerosis, rather than waiting.
The study showed that patients with a newly diagnosed multiple sclerosis had higher rates of pain fatigue, depression, and anxiety.
“We want to solve this problem immediately, not in 5 or 10 years,” said Kevin Alshuler, principal investigator of the study, which is funded by the RS National Society.
The original study in May and Fr. research companion observed the same group of patients, mostly white women, for one year after initial diagnosis to monitor their quality of life.
“Through symptom self-management, including cognitive-behavioral therapy, we help patients master coping skills, especially in the areas of fatigue and pain,” said Don Ede, co-author of a quality of life study published in May.
COPYRIGHT 2022 BY KXLY. ALL RIGHTS ARE PROTECTED. THIS MATERIAL CANNOT BE PUBLISHED, REPRODUCED, REPRODUCED OR REPRODUCED.
